Drug Trial Radar · NCT00002597
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Jun 14, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,028
Actual
Start
Oct 1994
Primary completion
Jul 2011
Study completion May 14, 2018
Sponsor
- Lead sponsor
- Radiation Therapy Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Feb 27, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Radiation therapy (RT) uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using flutamide, goserelin, and leuprolide may fight prostate cancer by reducing the production of androgens. It is not yet known which regimen of antiandrogen therapy is most effective for prostate cancer. PURPOSE: Randomized phase III trial to study the effectiveness of radiation therapy with or without antiandrogen therapy in treating patients who have stage I or stage II prostate cancer.
Conditions
- Prostate Cancer
Interventions
flutamideDrug
Two 125 mg capsules (t.i.d., p.o.) beginning two months before RT and continuing until RT is completed.
ZoladexDrug
3.6 mg s.c. monthly x 4 beginning two months before RT and continuing until RT is completed. The 3-month preparation may be used instead of three separate monthly injections.
LupronDrug
7.5 mg IM (intramuscular) monthly x 4 beginning two months before RT and continuing until RT is completed. The 3-month preparation may be used instead of three separate monthly injections.
radiation therapyRadiation
46.8 Gy (1.8 Gy/day four to five times a week \[26 fx\]) to regional lymphatics followed by 19.8 Gy (1.8 Gy/day x 11 fx) for a total of 66.6 Gy to the prostate. Prostate only may be treated in defined circumstances.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival Rate (10-year)Time frame: From date of randomization to 10 years
Locations
239 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama
Huntsville Hospital System
Huntsville, Alabama
Comprehensive Cancer Institute of Huntsville
Huntsville, Alabama
MBCCOP - Gulf Coast
Mobile, Alabama
Alabama Oncology, LLC
Montgomery, Alabama
Radiation Oncology Associates of West Alabama
Tuscaloosa, Alabama
Providence Alaska Medical Center
Anchorage, Alaska
Arizona Cancer Center
Tucson, Arizona
Mount Diablo Medical Center
Concord, California
Cancer Center and Beckman Research Institute, City of Hope
Duarte, California
California Cancer Center
Fresno, California
Saint Agnes Cancer Center
Fresno, California
Glendale Memorial Hospital and Health Center
Glendale, California
Sutter Health Western Division Cancer Research Group
Greenbrae, California
University of California San Diego Cancer Center
La Jolla, California
Loma Linda University Medical Center
Loma Linda, California
Veterans Affairs Medical Center - Long Beach
Long Beach, California
USC/Norris Comprehensive Cancer Center and Hospital
Los Angeles, California
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California
CCOP - Bay Area Tumor Institute
Oakland, California
Cancer Care Center
Pomona, California
Radiation Oncology Center - Sacramento
Sacramento, California
Radiation Medical Group, Inc.
San Diego, California
UCSF Cancer Center and Cancer Research Institute
San Francisco, California
O'Connor Hospital
San Jose, California
CCOP - Santa Rosa Memorial Hospital
Santa Rosa, California
Memorial Hospital Cancer Center
Colorado Springs, Colorado
University of Colorado Cancer Center
Denver, Colorado
CCOP - Christiana Care Health Services
Wilmington, Delaware
Walter Reed Army Medical Center
Washington D.C., District of Columbia
Lykes Center for Radiation Therapy
Clearwater, Florida
Halifax Medical Center
Daytona Beach, Florida
Radiation Therapy Associates - Fort Myers
Fort Myers, Florida
University of Florida Health Science Center
Gainesville, Florida
Health First Holmes Regional Medical Center
Melbourne, Florida
dVeterans Affairs Medical Center - Miami
Miami, Florida
Sylvester Cancer Center, University of Miami
Miami, Florida
Baptist Hospital of Miami
Miami, Florida
CCOP - Mount Sinai Medical Center
Miami Beach, Florida
Florida Radiation Oncology Group
Orange Park, Florida
Showing 40 of 239 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.